因塞特医疗公布首款Mutcalr靶向单克隆抗体Inca033989在骨髓纤维化患者中的积极新数据,发布于2025年ASH会议。
因塞特医疗公布首款Mutcalr靶向单克隆抗体Inca033989在骨髓纤维化患者中的积极新数据,发布于2025年ASH会议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.